Thorne's law of differential focus - the NHS announcements with the least oomph are the most impactful. The latest Specialised Services delegation provides an apparent context of prevention, local choice and integrated pathways of care. But it contains a revealing sentence.........."specialised services account for a growing share of NHS expenditure and whilst this is the result of being able to treat more diseases and conditions than ever before, it creates an inexorable pressure on costs." The most ill patients and the most complex treatments. Going to be interesting to see how this works in practice given differential weighted capitated budgets that are not ring-fenced. Even if a medicine or technology remains a central pass-through, the services around it are not. The dominant message is more an instruction, not invitation, to move spec comm funding into other areas through changed LOCAL pathways. Less a freedom to vire than a necessity to meet budget. And the fallout sits not in London but in places like Bristol, Manchester, Oxford and Leeds. #nhs #nhsengland #specialisedservices #pharma #pharmaceuticalindustry #marketaccess #medtech #diagnostics #medicaldevices
David Thorne’s Post
More Relevant Posts
-
Are you feeling the strain of PHIN reporting to meet the CMA Order? For hospitals and PPU's struggling to meet the requirements of the CMA Order, there is a ready built solution that waiting for you. Amplitude Clinical Outcomes is the UK’s leading provider of electronic PROMS, Our system is trusted by hospitals and NHS private patient units to achieve compliance with the CMA Order in record time. If you’re responsible for PHIN reporting, let’s connect about how we can help streamline the process and make compliance achievable—quickly. #HealthcareCompliance #AmplitudeOutcomes #PHIN #PatientReportedOutcomes #HealthcareSupport
To view or add a comment, sign in
-
The latest from 340B Report: Fifth Hospital Sues HRSA for Authorizing ‘Unlawful’ J&J 340B Audits - https://lnkd.in/e82fbSAc Drugmakers Urge Federal Appeals Court to Dismiss California Health System’s 340B Whistleblower Lawsuit - https://lnkd.in/esBxh3Km Maximizing 340B Opportunities Through Effective Pharmacy Reconciliation - https://lnkd.in/eeAEhazq State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Minnesota, Missouri, Mississippi - https://lnkd.in/euGiBN8X Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report - https://lnkd.in/erH42EXn To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg. #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy
To view or add a comment, sign in
-
Have you signed up for tomorrow's 60-minute masterclass, Market Access NHS England In conversation with Neil Grubert? 🎯Key Learning Objectives: 🗝️ What does Neil think will be the key drivers of Access success for 2025 and beyond? 🗝️ What Access barriers will you need to overcome in England beyond launch? 🗝️ What is the outlook for Access and how does Life Sciences need to respond? ⏰Can't make it tomorrow? ⬇️ Register and we'll send you the recording so you can watch it in your own time! 👉LSAA Members register here: https://lnkd.in/e_CAPnPg 👈 🗣️Speaker: Neil Grubert 🎙️Host: Ian Chamberlain 🌐Find more masterclasses here: https://lnkd.in/eVJWfGih #MarketAccess #NHS #LifeSciences #Pharma #Healthcare #HealthPolicy
To view or add a comment, sign in
-
Dr. Hudson Garrett, FACHDM, FAHVAP, FACHE, FSHEA, FNAP, FIDSA will be speaking at the upcoming Premier Inc. Breakthroughs24 Conference in Washington, DC on Advancing Medical Device Safety. This hot topic is one that impacts every patients that receives a procedure across the continuum. By applying an evidence-based approach to risk mitigation with medical devices, we can greatly reduce the risks of adverse events to patients. #medicaldevicesafety #medicaldevice #patientsafety #infectioncontrol #infectiousdiseases #infectionprevention #FDA FDA APIC American Society for Health Care Risk Management (ASHRM) Society of Gastroenterology Nurses and Associates
To view or add a comment, sign in
-
What are the biggest challenges facing primary care in 2024–25? What can we expect to see given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? Register now to join our live webinar on Thursday 16th May at 2.00pm, where my colleague, Karen Cooper (Senior Consultant – NHS Insight & Interaction), will be interviewing a panel of NHS Associates about the current state and future of primary care, and what this means for industry. Register now at https://lnkd.in/eNKS996H Put your questions to our panellists: 🎤 Jack Wagstaff (Place Leader, Surrey Heartlands Health and Care Partnership, Chief Officer for North West Surrey Health and Care Alliance) 🎤 Zafran Azam (Head of Medicines Optimisation and Delivery, Derby City Place) 🎤 Dr Neil Forster (GP and PCN Clinical Director, Northumberland Medical Alliance) Learn more about this webinar and our panellists at https://lnkd.in/ekuqqUEt #NHSPrimaryCare #GPContract #PrimaryCare #NHSinsights #Pharma #Medtech #Diagnostics #NHSWhispers
NHS primary care panel: GP Contract and Operational Planning
https://mtechaccess.co.uk
To view or add a comment, sign in
-
What are the biggest challenges facing NHS primary care in 2024–25? What impact will these have on relationships with industry? In this NHS Whispers webinar, we will be exploring the future of primary care, and the current and potential impact of recent policy announcements with a panel of NHS Associates. To join us live tomorrow at 2.00pm, register now at: https://lnkd.in/eKX_GcZw Learn more about this free webinar at: https://lnkd.in/eWNH_CMu #NHS #primarycare #NHSinsights #NHSWhispers #marketaccess #GPcontract #planning #Pharma #Medtech #MedicalDevices #Diagnostics
NHS primary care panel: GP Contract and Operational Planning
https://mtechaccess.co.uk
To view or add a comment, sign in
-
Have you signed up for tomorrow's 60-minute masterclass, Market Access NHS England In conversation with Neil Grubert? 🎯Key Learning Objectives: 🗝️ What does Neil think will be the key drivers of Access success for 2025 and beyond? 🗝️ What Access barriers will you need to overcome in England beyond launch? 🗝️ What is the outlook for Access and how does Life Sciences need to respond? ⏰Can't make it tomorrow? ⬇️ Register and we'll send you the recording so you can watch it in your own time! 👉LSAA Members register here: https://lnkd.in/ePkid_Yf 👈 🗣️Speaker: Neil Grubert 🎙️Host: Ian Chamberlain 🌐Find more masterclasses here: https://lnkd.in/eA2xCDdy #MarketAccess #NHS #LifeSciences #Pharma #Healthcare #HealthPolicy
To view or add a comment, sign in
-
Sudden cardiac death is a major unsolved public health problem, accounting for ~20% of all deaths in Europe. Find out how the #PROFID project is aiming to improve current clinical practice with regard to protection from sudden cardiac death after myocardial infarction and update the #EuropeanSocietyofCardiology clinical guidelines. #Horizon2020 #SuddenCardiacDeath #ICD #MedicalResearch #HealthcareInnovation #EHRA_ESC #SCD #PROFIDEHRA EHRA President Gerhard Hindricks Jose Luis Merino Llorens https://lnkd.in/ergwYmU6
The PROFID EHRA clinical trial
https://www.youtube.com/
To view or add a comment, sign in
-
This #SaferPharmaciesSunday we are emphasising how crucial it is that #pharmacists are able to raise concerns at work without reprisal or fear. These concerns could impact on patient safety, so must be raised and resolved without delay. Raising concerns is the sixth commitment of the #SaferPharmacies Charter. Learn more: https://buff.ly/2FG8Ocr Not yet a member of the PDA? Join today. PDA membership is FREE to #PharmacyStudents and #TraineePharmacists! https://buff.ly/2SKVnLo
To view or add a comment, sign in
Head of National Policy and Programs at Boehringer Ingelheim
1wWhat does prevention look like for a specialised condition / rare disease?